XERS PEER ANALYSIS

Xeris Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

XERSXeris Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

XERSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	XERS	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
P/E	123.82	—	—	46.82	22.16●	30.79	21.35
P/B	114.27	-0.87●	0.80	3.47	4.33	1.94	1.77
EV/EBITDA	30.62	4.05●	33.84	14.07	14.69	18.90	12.18
P/S	4.72	0.20●	5.03	1.86	3.94	3.87	2.08

Financial Health
Metric	XERS	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Current Ratio	2.12	1.32	1.73	1.33	3.66●	0.92	2.22
Debt/Equity	286.9%	-1,010.0%●	5.9%	41.0%	17.0%	52.3%	46.3%
NetDebt/EBITDA	-1.61●	3.71	-0.10	1.10	0.09	3.50	1.24

Profitability
Metric	XERS	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Net Margin	3.8%	-13.5%	-3.6%	4.0%	17.8%●	12.6%	4.0%
ROE	—	—	-0.6%	8.7%	20.9%●	6.3%	6.4%
ROA	3.4%	-4.7%	-0.5%	4.8%	15.1%●	3.2%	3.4%
EBITDA Margin	14.7%	60.0%●	14.8%	14.3%	27.0%	25.2%	18.2%

Growth + Dividend
Metric	XERS	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Rev. Growth	41.5%●	-9.9%	-2.3%	16.3%	-3.4%	-26.7%	7.5%
NI Growth	—	—	—	146.6%●	-5.9%	-14.2%	5.0%
Div. Yield	—	0.0%	2.6%●	0.0%	1.6%	2.0%	2.0%
Payout	—	0.0%	-365.1%	0.0%	36.3%	40.0%	0.8%

Valuation
Metric	XERS	COLL	PRGO	PAHC	HROW	ANIP	Ind. Median
P/E	123.82	20.03	—	14.71●	—	20.44	21.35
P/B	114.27	4.81	0.62●	3.87	58.27	3.26	1.77
EV/EBITDA	30.62	3.09●	—	9.37	59.71	7.88	12.18
P/S	4.72	1.89	0.37●	0.93	6.23	1.98	2.08

Financial Health
Metric	XERS	COLL	PRGO	PAHC	HROW	ANIP	Ind. Median
Current Ratio	2.12	1.71	2.72	3.17●	2.48	3.12	2.22
Debt/Equity	286.9%	258.6%	152.3%	217.6%	1,047.4%	58.3%●	46.3%
NetDebt/EBITDA	-1.61	0.63	-2.78●	3.15	6.55	0.07	1.24

Profitability
Metric	XERS	COLL	PRGO	PAHC	HROW	ANIP	Ind. Median
Net Margin	3.8%	9.4%	-43.5%	6.3%	-5.6%	9.7%●	4.0%
ROE	—	27.4%	-53.0%	30.3%●	-35.1%	17.8%	6.4%
ROA	3.4%	4.6%	-20.5%	6.9%●	-3.8%	6.6%	3.4%
EBITDA Margin	14.7%	76.6%●	-29.7%	15.0%	11.7%	25.4%	18.2%

Growth + Dividend
Metric	XERS	COLL	PRGO	PAHC	HROW	ANIP	Ind. Median
Rev. Growth	41.5%●	19.9%	-3.6%	26.0%	26.2%	37.0%	7.5%
NI Growth	—	70.7%	—	199.6%●	—	—	5.0%
Div. Yield	—	—	11.3%●	1.5%	—	0.0%	2.0%
Payout	—	—	-8.7%	20.4%	—	0.8%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on XERS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.